Background
==========

The ankle-foot orthosis (AFO) is an important component of lower limb orthoses, providing cushioning and support \[[@b1-medscimonit-25-1392]--[@b3-medscimonit-25-1392]\]. AFOs are designed based on biomechanical principles to reduce stress, relieve pain, correct deformities, and enhance the stability of the foot. They are used to prevent and treat diseases of the feet and lower limbs \[[@b4-medscimonit-25-1392],[@b5-medscimonit-25-1392]\]. Studies have shown that orthopedic insoles help prevent and correct knee arthritis as well as lumbar pain and foot deformities, improving gait in patients with lower extremity arthritis and improving walking function \[[@b6-medscimonit-25-1392],[@b7-medscimonit-25-1392]\]. Plantar fasciitis (PF) is also called jogger's heel, tennis foot, and police foot. It is a common foot musculoskeletal disease; PF is caused by aseptic inflammation of the tendon or fascia of the foot \[[@b8-medscimonit-25-1392]\]. PF leads to reduced daily activities, and patients' feet often feel hot and painful. Initial treatment of PF includes filling, foot straps, orthopedic insoles, and topical corticosteroid injections \[[@b9-medscimonit-25-1392]--[@b11-medscimonit-25-1392]\]. If the symptoms persist after 1 year of first-line treatment, surgery is required \[[@b12-medscimonit-25-1392],[@b13-medscimonit-25-1392]\]. AFOs are the most common method of rehabilitation for the initial treatment of PF \[[@b8-medscimonit-25-1392],[@b14-medscimonit-25-1392]\]. Compared with personalized AFOs, traditional methods of AFO have many deficiencies, including complicated manufacturing processes, long production time, and problems related to patients wearing AFOs. They are prone to causing discomfort, making it difficult for patients to integrate them into use \[[@b3-medscimonit-25-1392],[@b6-medscimonit-25-1392]\]. 3D printing technology is essentially a computer-aided design and computer-aided manufacturing process (CAD-CAM). 3D printing technology has the advantages of fast construction and on-demand production that meets the needs of individualized medical treatment \[[@b1-medscimonit-25-1392],[@b7-medscimonit-25-1392]\]. 3D printed AFOs have been in the research and experimental stage in recent years, and actual use is primarily based on commercial customization without clinical verification \[[@b15-medscimonit-25-1392]\]. Based on these preconditions, the aim of the study was to test whether customized 3D printed AFOs might have a better effect on improving comfort and changing foot biomechanics in people with plantar fasciitis compared with conventional prefabricated insoles.

Material and Methods
====================

General information
-------------------

Seventy-five patients with PF were recruited from the Bethune Second Hospital of Jilin University from January 2018 to October 2018 by random sampling. Informed consent was obtained from all participants. The Ethics Committee of the Second Hospital of Jilin University approved the study. Subsequently, 60 patients (30 females and 30 males) met the inclusion criteria and agreed to participate in the study. Participants were between the ages of 31 and 60 years. The course of disease was 5--10 months (mean ± standard deviation, 20.5±6.4 months). The sample size of 60 participants was chosen because it proved to be large enough to allow parameter statistics during data analysis \[[@b4-medscimonit-25-1392],[@b16-medscimonit-25-1392]--[@b19-medscimonit-25-1392]\]. A power calculation was not performed because of the uncertainty surrounding the minimal important difference for plantar pressure changes. [Table 1](#t1-medscimonit-25-1392){ref-type="table"} lists the demographics of the participants. Patients were divided into an experimental group and a control group according to the random number table method. There were no significant differences with respect to age and weight, body mass index (BMI), and AFO wearing time (*P*\>0.05).

Inclusion and exclusion criteria
--------------------------------

The following inclusion/exclusion criteria were used to determine eligibility for enrollment in this clinical trial. Inclusion criteria were: 1) males or females with a diagnosis of PF, 2) aged 31--60 years, and 3) the diagnosis was made upon the finding of tenderness to pressure at the origin of the plantar fascia on the medial tubercle of the calcaneus, as well as complaint of heel pain greater than or equal to 3 on a 1--10 visual analogue scale (VAS). Exclusion criteria were: 1) previous fracture or surgery of the foot, and 2) specific metabolic and connective tissue disorders associated with or contributing to the diagnosis of PF (e.g., rheumatoid arthritis, gout, and lupus).

Study design
------------

This study had a single-blind, randomized, controlled design. Randomization was performed by one independent therapist (TM). The patients were subsequently randomized to either the experimental group (customized AFO-wearing group) or the control group (prefabricated-AFO wearing group). We used a computer-generated table of random numbers which were encrypted and not readable until allocation. One independent research assistant (RX) performed all assessments and data entry. Except for the interview, the assistant worked at another location and did not participate in the treatment, allowing the single-blind treatment allocation to be maintained. Before each measurement, the assistant was asked to confirm a lack of knowledge regarding the treatment allocations. Assessments were performed at baseline and at the end of the 8-week treatment.

Experimental and control groups
-------------------------------

All participants wore standardized thin cotton socks and their commonly-used shoes during the test, as well as flat shoes and socks that are uniformly purchased by the hospital 1 month before the experiment. The sole was flat and did not significantly change the original pressure and contact area of the patient's sole. The control group wore commonly used shoes + traditional pre-made sponge orthopedic insoles (control group). The experimental group wore commonly used shoes + customized vinyl acetate (EVA) orthopedic insoles (experimental group).

Customized foot orthoses were manufactured by the commercial orthosis manufacturer (Bodyarch), using computer-aided design and computer-aided manufacturing (CAD-CAM). The patient's foot model was first obtained using a 0.5 m^2^ plantar pressure plate-pressure collection device. The Footscan^®^ 3D gait analysis system (RSscan International, Olen, Belgium) was used to obtain patient gait, the Bodyarch cloud data acquisition system was used to summarize these data, and we used the Bodyarch function insole cloud design system. The 3D AFO was made using the Bodyarch X1 printer, where each orthosis was cast on the front side and the material was polyethylene acetate (EVA). In order to eliminate psychological factors, the control group patients also underwent this procedure; however, we did not make a customized orthosis for them, and the printed orthoses and pre-made orthoses were inserted into the corresponding participants' shoes, with the participants not knowing the insert status. They were only informed that the purpose of the study was to evaluate the effects of 2 different types of shoe inserts \[[@b20-medscimonit-25-1392]\] that were considered to have different therapeutic mechanisms. After each test was completed under each insertion condition, participants assessed the overall comfort of their foot orthosis during the test (0=completely uncomfortable, 10=most comfortable). We also evaluated the ease of use and stability of each insole. Participants did not know the measurement results and ratings. After completing each insertion condition, the participants rated the shoes separately. The interval between the shoe insertion conditions was approximately 10 minutes, during which time the participants walked barefoot around the laboratory at a slow pace of their choice. [Figure 1](#f1-medscimonit-25-1392){ref-type="fig"} shows a customized ankle orthosis and pre-made ankle orthosis.

Experimental process
--------------------

Footscan^®^ 7-gait 2^nd^ generation system (2096×472×18 mm, 16 384 resistance sensors arranged in a 256×64 matrix with a resolution of 2 sensors/cm^2^) captured the dynamic pressure of the foot data. The system has been shown to accurately test plantar pressure \[[@b21-medscimonit-25-1392],[@b22-medscimonit-25-1392]\]. The acquisition frequency was 125 Hz and the pressure range was 0--200 N/cm^2^; the system was connected to the computer using the supplied cable. The platform was located in the center of the floor to provide a "full platform" of 4 meters \[[@b23-medscimonit-25-1392]\]. Following the manufacturer's manual, the Footscan^®^ system was calibrated prior to each measurement. According to a study by Xu et al. \[[@b21-medscimonit-25-1392]\], in order to obtain more accurate parameters, no walking mat was placed above the flat plate. During calibration, the patient's weight was entered into the computer and the patient was asked to pass across the plate at a normal rate while barefoot; the software automatically calibrated all parameters. Because the Footscan^®^ system can measure the distribution of foot pressure, the pressure change of the lesion area can be detected, which means that the system can be used as an auxiliary means to measure comfort when wearing AFOs \[[@b24-medscimonit-25-1392]--[@b26-medscimonit-25-1392]\].

After correction conditions, the plantar pressure data were recorded (i.e., week 0). The participant was told that they were undergoing a foot orthosis test and were not provided additional information. The experimental group and the control group were analyzed in random order to minimize potential errors. Participants were unaware of the conditions tested in the initial data collection. Because it was difficult to conceal the condition of each orthosis, the researchers did not use the blinded method. They inserted the orthopedic insole into the shoe under each test condition, and zeroed the system according to the manufacturer's instructions before the first walk test. After 2 minutes of acclimatization of standing and walking, the participants completed 3 walks along each 10-m walkway under each condition, and each test involved a stopwatch to control walking speed. If the trial was not within 5% of the original walking time, the trial was repeated to minimize the effect of walking speed on plantar pressure \[[@b27-medscimonit-25-1392]\]. The average walking speed of all trials was 3.5 km/hour (±3.0 km/hour). Once the initial plantar pressure was collected, orthoses were then provided to the participants so that they could begin to wear them within the next 8 weeks. During the subsequent 8 weeks, participants were instructed to wear each orthosis at the same time. No rehabilitation treatment was carried out between the 8 weeks. After 8 weeks, participants returned for a second data collection of plantar pressure based on the identical data collection protocol used initially. Similar to the initial data collection, participants were unaware of the 8^th^ week of data collection testing specific grouping information.

Visual analogue scale (VAS)
---------------------------

A VAS was used to measure comfort when wearing AFOs \[[@b28-medscimonit-25-1392]--[@b30-medscimonit-25-1392]\]. VAS is a numerical scale with marked points at 0 and 10, in which 0 indicates no discomfort and 10 indicates the highest level of discomfort. The scale was 10-cm long and was on a single piece of white paper. Patients were requested to rate their comfort based on their initial steps at week 0 and week 8 by putting a vertical mark on the scale representing the level of comfort. The patient was only shown a single scale on each visit to avoid prejudice.

Data analysis
-------------

Using the Footscan^®^ system to analyze plantar pressure data, the software automatically divided the foot into 10 coverage areas: the big toe (T1), toes 2--5 (T2--T5), the first to fifth metatarsal (M1, M2, M3, M4, and M5), midfoot (MF), medial heel (H1), and lateral heel (H2) ([Figure 2](#f2-medscimonit-25-1392){ref-type="fig"}). The primary data collected were peak pressure, contact area, and maximum force at T1, T2--T5, M1, M2, M3, M4, M5, and MF at zero and 8 weeks. Statistical analysis was performed using Social Science Statistics Program (SPSS) 20^th^ Edition (SPSS Inc., Chicago, IL, USA). One-way analysis of variance (ANOVA) was used to compare the mean and significance between test conditions. In order to maintain data independence, only the left foot of each participant was selected for evaluation \[[@b31-medscimonit-25-1392]\].

The statistical significance of the test was set to the conventional level of *P*\<0.05. To reduce the effects of body acceleration and deceleration at the beginning and end of the walking test, 5 intermediate steps were selected by the step analysis software of the Footscan^®^ system. VAS scores of the experimental and control groups were collected at weeks 0 and 8 and were compared between groups.

Results
=======

Comfort score
-------------

After wearing the AFO at week 0, the VAS of the experimental group was 7.34± 3.43 and the VAS of the control group was 8.72±3.93. There was no significant difference between the experimental group and the control group (*P*\>0.05). After 8 weeks, all participants reported comfort increase. The comfort score reported by the experimental group (3.12± 0.51) was significantly lower than that of the control group (5.25±1.22, *P*\<0.05) (0=most comfortable, 10 = completely uncomfortable).

Biomechanical analysis
----------------------

The comparison of the experimental group and the control group at week 0 is shown in [Table 2](#t2-medscimonit-25-1392){ref-type="table"}. The overall differences were small for peak pressure, peak strength, and contact area of the 10 regions of the experimental group and the control group at week 0. Walking with a customized AFO, the peak pressure of the hallux, and first metatarsal area was much higher than the peak pressure generated when using the prefabricated AFO (*P*\<0.05). In the mid-heel and lateral foot, the peak pressure was much lower in the experimental group than in the control group (*P*\<0.05). In other areas, there were no significant differences between the experimental group and the control group. There were no significant differences between the experimental group and the control group with respect to peak strength or contact area.

The comparison of the experimental group and the control group in the 8^th^ week is shown in [Table 3](#t3-medscimonit-25-1392){ref-type="table"}.

The 3 parameters of the experimental and control groups showed no significant differences in all regions.

The comparison between week 0 and week 8 of the control group is shown in [Table 4](#t4-medscimonit-25-1392){ref-type="table"}.

At weeks 0 and 8, there were no significant differences in all areas except for the difference in the contact area of the first fifth metatarsal area.

[Table 5](#t5-medscimonit-25-1392){ref-type="table"} displays the experimental group comparison between weeks 0 and 8 in terms of peak pressure. The peak pressure in the big toe area of patients wearing a customized AFO at week 8 was significantly higher than the peak pressure in the corresponding region at week 0 (T1: *P*=0.02). There were no significant differences between the experimental groups at weeks 0 and 8 in terms of peak strength or contact area.

Discussion
==========

The concept of making an AFO
----------------------------

The purpose of the AFO is to support the arch and increase the contact area. In addition to compensating for the drop of the arch, the AFO can also reduce the recoil force when the heel strikes, improving the pressure distribution of the plantar region, and helping to reconstruct external rotation to obtain proper thrust \[[@b32-medscimonit-25-1392]\]. It has a positive effect on improving comfort and assisting rehabilitation in patients with plantar fasciitis. This study was designed to compare the effects of customized 3D printed AFOs with those of conventional prefabricated insoles on biomechanics and comfort in the plantar foot in patients with plantar fasciitis.

Comparison of biomechanical effects of 2 orthoses on plantar fasciitis in patients with plantar fasciitis
---------------------------------------------------------------------------------------------------------

In the midfoot area, there were no significant within-group differences between the experimental group and the control group. This indicates that, for patients with plantar fasciitis, a rehabilitation effect in the mid-foot area occurred regardless of the type of AFO used.

In the heel area, because patients with plantar fasciitis primarily develop heel pain and the heel is the lesion area, the distribution of the heel load has a positive effect on alleviating the pressure and improving the condition of the patient. Compared with the foot orthosis, the customized AFO significantly reduced the heel pressure at time zero; however, the long-term effect was not significantly different from that of the control group, suggesting that the customized AFO can have orthotic effect in a shorter time. However, it requires long-term wear to produce a stable healing effect.

In the metatarsal region, the peak pressure of the first metatarsal was much higher in the experimental group at week 0 than in the control group, suggesting that the customized AFO transfers the load from the forefoot region to the hind foot to improving comfort, while the prefabricated AFO has a slower effect on the transfer load. It has been experimentally demonstrated that foot orthoses can decompress the metatarsal region \[[@b33-medscimonit-25-1392]\]. Guldemond et al. \[[@b34-medscimonit-25-1392]\] found that the reason for the reduction of the first metatarsal pressure was the use of a metatarsal pad and the improved height of the arch support; these results indicate that the printed insole is more suitable for actual foot conditions. In this experiment, the lesion of the plantar fasciitis was primarily in the hind foot. By reducing forefoot pressure, the hind foot load can be relieved \[[@b9-medscimonit-25-1392]\]; in the study of Farzadi et al. \[[@b35-medscimonit-25-1392]\], the direct effect of the foot orthosis was not significant; however, after using the foot orthosis for 1 month, the pressure and strength were significantly reduced in these areas. We believe that, because the customized AFO is more in line with the actual foot condition of the patient, the correction effect is produced in a short time, and the correction effect is enhanced as time passes.

In the toe area, similar to the metatarsal area, only at week 0 was the peak pressure of the toe area of the experimental group much higher than that of the control group, possibly because of the increased pressure of the toe area caused by the plantar lesion. Simply distributing the load to the toe area through the orthosis does not provide an effective therapeutic effect \[[@b36-medscimonit-25-1392]\] and needs to be combined with other rehabilitation methods.

Comfort is also a factor affecting the use of the foot orthosis. Uncomfortable orthoses can have a negative impact on lower limb balance control and patient mood \[[@b1-medscimonit-25-1392],[@b31-medscimonit-25-1392]\], especially for the elderly \[[@b37-medscimonit-25-1392]\]. This experiment shows that the comfort of the customized AFO is much higher than the prefabricated AFO, and has a long-term effect, potentially improving the treatment effect.

The results of this study have some limitations. First, this study only covered the comparison of 2 types of foot orthoses, without considering other types of materials \[[@b7-medscimonit-25-1392],[@b16-medscimonit-25-1392]\] and the shape of the AFO \[[@b38-medscimonit-25-1392]\]; second, although Footscan^®^ has been shown to be an effective and reliable plantar pressure system \[[@b21-medscimonit-25-1392],[@b22-medscimonit-25-1392],[@b31-medscimonit-25-1392]\], the technique of measuring the pressure inside the shoe continues to produce errors \[[@b39-medscimonit-25-1392]\]. For example, when measuring the contact area, the full surface of the foot cannot be fully obtained. Finally, our sample size was not sufficient and there were certain errors.

Conclusions
===========

This study supports the efficiency of customized 3D printing AFO for reducing damage associated with plantar lesions and improving comfort in patients with plantar fasciitis compared with prefabricated AFO.

**Source of support:** Departmental sources

![(**A**) Experimental group: customized ankle orthosis. (**B**) Control group: pre-made ankle orthosis.](medscimonit-25-1392-g001){#f1-medscimonit-25-1392}

![The Footscan^®^ system divides the sole into 10 coverage areas: the hallux (T1), toes 2--5 (T2--T5), the first to fifth metatarsal (M1, M2, M3, M4, and M5), midfoot (MF), medial heel (H1, MH), and lateral heel (H2, LH).](medscimonit-25-1392-g002){#f2-medscimonit-25-1392}

###### 

Demographics of participants (N=60).

  Characteristics            Experimental group     Control group                          
  -------------------------- ---------------------- --------------- ---------------------- --------------
  Age (years)                40.31 (5.21)           31--58          42.52 (6.18)           33--60
  Sex                        15 males, 15 females                   15 males, 15 females   
  Weight (Kg)                62.17 (10.52)          49.42--88.94    65.28 (9.72)           50.92--86.42
  BMI (Kg/m^2^)              26.56 (12.42)          15.93--29.74    25.71 (10.42)          17.44--28.33
  Wearing time (hours/day)   6.41 (3.32)            3.32--9.72      5.11 (2.54)            4.31--8.72

SD -- standard deviation.

###### 

Comparison of the experimental group and the control group at week 0.

  Areas    Peak pressure (kPa)   Maximum force (N)   Contact area (cm^2^)                                                                                                   
  -------- --------------------- ------------------- ----------------------------------------------------------- ------------- ------------- ------- ---------- ----------- -------
  T1       90.0±19.5             59.0±26.1           0.012[\*](#tfn2-medscimonit-25-1392){ref-type="table-fn"}   93.0±21.8     95.9±44.0     0.912   10.0±1.3   16.4±4.8    0.112
  T2--T5   46.7±19.0             31.0±26.8           0.532                                                       65.2±57.3     39.9±52.2     0.623   12.1±5.8   8.1±7.1     0.521
  M1       125.0±51.0            34.2±31.3           0.041[\*](#tfn2-medscimonit-25-1392){ref-type="table-fn"}   90.7±30.4     36.9±40.0     0.112   7.6±3.5    8.1±3.3     0.822
  M2       223.1±38.2            316.6±335.6         0.623                                                       172.0±39.7    128.3±108.7   0.541   7.3±0.5    8.1±3.1     0.631
  M3       241.2±78.1            350.3±287.5         0.421                                                       169.0±65.8    288.1±271.4   0.443   6.6±1.0    7.5±0.8     0.221
  M4       239.3±93.5            296.4±166.1         0.643                                                       184.2±80.2    241.0±140.7   0.522   7.3±0.9    7.9±0.85    0.134
  M5       192.1±95.3            152.4±93.2          0.623                                                       241.2±132.7   183.9±96.2    0.631   12.1±2.4   12.2±1.3    0.942
  MF       119.2±21.6            61.2±67.0           0.212                                                       396.0±143.0   314.2±416.0   0.714   31.8±8.9   42.6±10.8   0.221
  MH       119±13.7              196±37.6            0.042[\*](#tfn2-medscimonit-25-1392){ref-type="table-fn"}   211.1±125.2   243.5±75.5    0.622   14.1±4.5   11.8±1.6    0.242
  LH       128.2±29.3            207.1±47.2          0.021[\*](#tfn2-medscimonit-25-1392){ref-type="table-fn"}   220.9±162.8   220.2±73.2    0.942   12.7±4.8   10.1±1.4    0.232

*P*\<0.05 is considered a significant difference; values are expressed as means ± standard deviation;

CAFO -- customized AFO; PCAFO -- pre-customized AFO; T1 -- hallux; T2--T5 -- toes 2--5; M1 -- first metatarsal; M2 -- second metatarsal; M3 -- third metatarsal; M4 -- fourth metatarsal; M5 -- fifth metatarsal; MF -- midfoot; MH -- medial heel; LH -- lateral heel.

###### 

Comparison of the experimental and the control groups at week 8.

  Areas    Peak pressure (kPa)   Maximum force (N)   Contact area (cm^2^)                                                               
  -------- --------------------- ------------------- ---------------------- ------------- ------------- ------- ----------- ----------- -------
  T1       129.7±24.3            165.5±151.4         0.611                  157.0±48.9    126.8±48.9    0.312   11.5±1.3    13.2±9.3    0.712
  T2--T5   50.2±8.4              62.5±66.1           0.725                  66.2±34.8     43.8±38.7     0.723   12.1±5.2    10.7±7.0    0.521
  M1       140.0±0.8             176.5±229.7         0.754                  134.5±50.9    97.9±19.7     0.322   9.3±3.7     12.6±7.5    0.523
  M2       204.2±29.4            282.5±285.9         0.623                  189.2±69.7    177.8±62.3    0.841   8.8±2.2     10.7±6.2    0.622
  M3       408.0±454.9           287.2±129.8         0.632                  111.1±65.7    233.7±133.9   0.223   7.3±0.7     9.5±5.4     0.421
  M4       174.2±8.7             160.7±77.2          0.742                  138.0±25.2    138.2±111.8   0.912   7.6±1.4     9.3±5.3     0.623
  M5       109.5±30.3            72.2±39.5           0.232                  140.0±60.7    82.9±84.1     0.332   11.8±2.9    11.8±7.1    0.921
  MF       106.7±9.9             62.7±41.2           0.114                  334.5±131.4   146.8±162.5   0.123   29.9±10.8   27.5±17.5   0.834
  MH       229.2±38.5            191.0±100.4         0.554                  303.5±71.0    218.4±123.8   0.412   12.4±3.1    14.3±8.5    0.723
  LH       215.±3.6              227.5±140.4         0.832                  258.2±96.6    232.4±155.3   0.825   11.3±2.7    13.1±7.7    0.742

*P*\<0.05 is considered a significant difference; values are expressed as means ± standard deviation;

CAFO -- customized AFO; PCAFO -- pre-customized AFO; T1 -- hallux; T2--T5 -- toes 2--5; M1 -- first metatarsal; M2 -- second metatarsal; M3 -- third metatarsal; M4 -- fourth metatarsal; M5 -- fifth metatarsal; MF -- midfoot; MH -- medial heel; LH -- lateral heel.

###### 

Comparison of week 0 and week 8 in the control group.

  Areas    Peak pressure (kPa)   Maximum force (N)   Contact area (cm^2^)                                                                                                                   
  -------- --------------------- ------------------- ---------------------- ------------- ------------- ----------------------------------------------------------- ----------- ----------- -------
  T1       59.5±26.2             165.5±151.4         0.312                  95.9±44.0     126.8±48.9    0.323                                                       16.4±4.8    13.2±9.3    0.612
  T2--T5   31.0±26.9             62.5±66.1           0.532                  39.9±52.2     43.8±38.7     0.835                                                       8.1±7.1     10.7±7.0    0.553
  M1       34.7±31.0             176.5±229.7         0.343                  36.9±40.0     97.9±19.7     0.042[\*](#tfn6-medscimonit-25-1392){ref-type="table-fn"}   8.1±3.3     12.6±7.5    0.223
  M2       316.7±335.3           282.5±285.9         0.934                  128.3±108.7   177.8±62.3    0.435                                                       8.1±3.1     10.7±6.2    0.543
  M3       350.0±287.0           287.2±129.8         0.734                  288.1±271.4   233.7±133.9   0.635                                                       7.5±0.8     9.5±5.4     0.523
  M4       296.2±166.0           160.7±77.2          0.223                  241.0±140.7   138.2±111.8   0.264                                                       7.9±0.8     9.3±5.3     0.643
  M5       152.2±9.3             72.2±39.5           0.082                  183.9±96.2    82.9±84.1     0.033[\*](#tfn6-medscimonit-25-1392){ref-type="table-fn"}   12.2±1.3    11.8±7.14   0.923
  MF       61.0±67.4             62.7±41.2           0.925                  314.2±416.0   146.8±162.5   0.234                                                       42.6±10.8   27.5±17.5   0.143
  MH       119.2±13.0            191.0±100.4         0.263                  211.0±125.2   218.4±123.8   0.953                                                       14.1±4.5    14.3±8.5    0.932
  LH       128.0±29.7            227.5±140.4         0.223                  220.9±162.8   232.4±155.3   0.923                                                       12.7±4.8    13.1±7.7    0.934

*P*\<0.05 is considered a significant difference; values are expressed as means ± standard deviation;

0PCAFO -- week 0 pre-customized AFO; 8PCAFO -- week 8 pre-customized AFO; T1 -- hallux; T2--T5 -- toes 2--5; M1 -- first metatarsal; M2 -- second metatarsal; M3 -- third metatarsal; M4 -- fourth metatarsal; M5 -- fifth metatarsal; MF -- midfoot; MH -- medial heel; LH -- lateral heel.

###### 

Comparison of week 0 and week 8 in the experimental group.

  Areas    Peak pressure (kPa)   Maximum force (N)   Contact area (cm^2^)                                                                                                   
  -------- --------------------- ------------------- ----------------------------------------------------------- ------------- ------------- ------- ---------- ----------- -------
  T1       105.7±27.8            141.1±34.9          0.022[\*](#tfn8-medscimonit-25-1392){ref-type="table-fn"}   131.0±62.6    171.4±57.0    0.123   11.5±2.6   11.5±1.0    0.964
  T2--T5   48.1±16.9             54.4±19.5           0.342                                                       65.0±45.7     63.4±30.0     0.842   12.1±4.8   11.1±4.2    0.432
  M1       134.0±39.7            150.2±15.6          0.324                                                       118.2±61.0    144.1±44.4    0.324   8.8±4.0    9.3±2.9     0.635
  M2       221.2±38.6            204.2±38.1          0.123                                                       196.7±68.7    201.8±83.2    0.753   8.4±1.9    9.2±2.2     0.232
  M3       238.2±77.4            346.5±336.6         0.321                                                       187.0±84.6    159.3±101.0   0.323   7.3±1.6    7.5±0.9     0.553
  M4       226.0±84.5            172.5±34.8          0.132                                                       183.2±78.1    149.2±49.6    0.254   7.7±1.1    8.2±1.6     0.072
  M5       163.1±80.5            116.2±55.7          0.142                                                       190.8±116.8   127.2±63.0    0.124   11.0±2.3   10.3±2.9    0.133
  MF       111.1±26.7            99.7±18.6           0.123                                                       390.4±150.0   360.0±148.5   0.253   33.1±8.3   34.5±12.5   0.523
  MH       195.7±27.6            220.5±33.5          0.143                                                       272.0±88.9    314.0±90.6    0.073   13.2±3.3   13.8±3.6    0.442
  LH       196.2±36.7            212.4±32.4          0.121                                                       234.7±76.6    269.1±96.8    0.082   11.5±3.1   12.1±2.9    0.343

*P*\<0.05 is considered a significant difference; values are expressed as means ± standard deviation;

0CAFO -- week 0 customized AFO; 8CAFO -- week 8 customized AFO; T1 -- hallux; T2--T5 -- toes 2--5; M1 -- first metatarsal; M2 -- second metatarsal; M3 -- third metatarsal; M4 -- fourth metatarsal; M5 -- fifth metatarsal; MF -- midfoot; MH -- medial heel; LH -- lateral heel.
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